Windtree Therapeutics to Be Delisted from NASDAQ for Failing to Meet Minimum Closing Price Standards

Deep News

2025/08/21

Windtree Therapeutics, dubbed the "BNB MicroStrategy" company, received notification from NASDAQ on August 19, 2025, that its common stock will be delisted from the NASDAQ Capital Market on August 21 due to failure to meet the minimum closing price maintenance standards under Rule 5550(a)(2). The stock will subsequently transfer to OTC market trading.

Previously, the company had announced plans to raise up to $520 million through equity financing, with 99% of the proceeds intended for purchasing BNB.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1192236024"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192236024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192236024?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-21 02:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192236024","market":"sg","top_or_hot":-1,"title":"Windtree Therapeutics to Be Delisted from NASDAQ for Failing to Meet Minimum Closing Price Standards","media":"Deep News","content":"<p>Windtree Therapeutics, dubbed the \"BNB MicroStrategy\" company, received notification from NASDAQ on August 19, 2025, that its common stock will be delisted from the NASDAQ Capital Market on August 21 due to failure to meet the minimum closing price maintenance standards under Rule 5550(a)(2). The stock will subsequently transfer to OTC market trading.</p>\n<p>Previously, the company had announced plans to raise up to $520 million through equity financing, with 99% of the proceeds intended for purchasing BNB.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Windtree Therapeutics to Be Delisted from NASDAQ for Failing to Meet Minimum Closing Price Standards</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWindtree Therapeutics to Be Delisted from NASDAQ for Failing to Meet Minimum Closing Price Standards\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-08-21 02:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Windtree Therapeutics, dubbed the \"BNB MicroStrategy\" company, received notification from NASDAQ on August 19, 2025, that its common stock will be delisted from the NASDAQ Capital Market on August 21 due to failure to meet the minimum closing price maintenance standards under Rule 5550(a)(2). The stock will subsequently transfer to OTC market trading.</p>\n<p>Previously, the company had announced plans to raise up to $520 million through equity financing, with 99% of the proceeds intended for purchasing BNB.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_NQ","symbol_name":"NQ100指数","start_time":0,"source_url":"","article_id":"1192236024","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192236024","pubTimestamp":1755714689,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Windtree Therapeutics, dubbed the \"BNB MicroStrategy\" company, received notification from NASDAQ on August 19, 2025, that its common stock will be delisted from the NASDAQ Capital Market on August 21...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159632":"纳斯达克","QLD":"2倍做多纳斯达克100指数ETF-ProShares","NDX":"纳斯达克100指数","USJW.SI":"ALPHAB 3xLongSG261006","SQQQ":"纳指三倍做空ETF","TSYW.SI":"TESLA 3xLongSG261006","LENZ":"Therapeutics","NVIW.SI":"NVDA 3xLongSG261006","QID":"两倍做空纳斯达克指数ETF-ProShares","BK4007":"制药","ARTL":"Artelo Biosciences, Inc.","USAW.SI":"AMZN 3xLongSG261006","BK4539":"次新股","PSQ":"做空纳斯达克100指数ETF-ProShares","03086":"华夏纳指",".IXIC":"NASDAQ Composite","QQQ":"纳指100ETF","BK1147":"投资银行业与经纪业","BK4139":"生物科技","TQQQ":"纳指三倍做多ETF"},"translate_title":"Windtree Therapeutics因未达到最低收盘价标准将从纳斯达克退市","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159632":1,"USAW.SI":1,"QQQ":1,"ARTL":1,".IXIC":1,"QLD":1,"TQQQ":1,"USJW.SI":1,"TSYW.SI":1,"QID":1,"03086":1,"NQmain":1,"NVIW.SI":1,"SQQQ":1,"NDX":1,"LENZ":1,"MNQmain":1,"PSQ":1},"content_text":"Windtree Therapeutics, dubbed the \"BNB MicroStrategy\" company, received notification from NASDAQ on August 19, 2025, that its common stock will be delisted from the NASDAQ Capital Market on August 21 due to failure to meet the minimum closing price maintenance standards under Rule 5550(a)(2). The stock will subsequently transfer to OTC market trading.\nPreviously, the company had announced plans to raise up to $520 million through equity financing, with 99% of the proceeds intended for purchasing BNB.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}